A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

October 17, 2003

Primary Completion Date

November 1, 2004

Study Completion Date

November 30, 2004

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

rosiglitazone/metformin

Trial Locations (94)

1311

GSK Investigational Site, Auckland

1701

GSK Investigational Site, Auckland

2050

GSK Investigational Site, Camperdown

2065

GSK Investigational Site, St Leonards

2500

GSK Investigational Site, Wollongong

3162

GSK Investigational Site, Caulfield

3201

GSK Investigational Site, Rotorua

4021

GSK Investigational Site, Kippa-Ring

4102

GSK Investigational Site, Woolloongabba

5006

GSK Investigational Site, North Adelaide

6000

GSK Investigational Site, Perth

6035

GSK Investigational Site, Wellington

6959

GSK Investigational Site, Fremantle

8001

GSK Investigational Site, Christchurch

10024

GSK Investigational Site, New York

10029

GSK Investigational Site, New York

10032

GSK Investigational Site, New York

12401

GSK Investigational Site, Kingston

14609

GSK Investigational Site, Rochester

18974

GSK Investigational Site, Warminster

19335

GSK Investigational Site, Downingtown

19382

GSK Investigational Site, West Chester

28210

GSK Investigational Site, Charlotte

30189

GSK Investigational Site, Woodstock

30214

GSK Investigational Site, Fayetteville

30308

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

32204

GSK Investigational Site, Jacksonville

32806

GSK Investigational Site, Orlando

32901

GSK Investigational Site, Melbourne

33156

GSK Investigational Site, Miami

34769

GSK Investigational Site, Saint Cloud

36207

GSK Investigational Site, Anniston

37601

GSK Investigational Site, Johnson City

39202

GSK Investigational Site, Jackson

44260

GSK Investigational Site, Mogadore

47630

GSK Investigational Site, Newburgh

47713

GSK Investigational Site, Evansville

60607

GSK Investigational Site, Chicago

63017

GSK Investigational Site, Chesterfield

63376

GSK Investigational Site, St Louis

64111

GSK Investigational Site, Kansas City

70461

GSK Investigational Site, Slidell

75230

GSK Investigational Site, Dallas

76017

GSK Investigational Site, Arlington

77701

GSK Investigational Site, Beaumont

77802

GSK Investigational Site, Bryan

78221

GSK Investigational Site, San Antonio

78237

GSK Investigational Site, San Antonio

78411

GSK Investigational Site, Corpus Christi

79705

GSK Investigational Site, Midland

85014

GSK Investigational Site, Phoenix

85050

GSK Investigational Site, Phoenix

85224

GSK Investigational Site, Chandler

85745

GSK Investigational Site, Tucson

89103

GSK Investigational Site, Las Vegas

92024

GSK Investigational Site, Encinitas

92691

GSK Investigational Site, Mission Viejo

92835

GSK Investigational Site, Fullerton

93635

GSK Investigational Site, Los Banos

98108

GSK Investigational Site, Seattle

98801

GSK Investigational Site, Wenatchee

99207

GSK Investigational Site, Spokane

T3E 0C5

GSK Investigational Site, Calgary

V3K 3V9

GSK Investigational Site, Coquitlam

V3A 4H9

GSK Investigational Site, Langley

E1G 1A7

GSK Investigational Site, Moncton

B3K 5R3

GSK Investigational Site, Halifax

L6T 3T1

GSK Investigational Site, Brampton

L7M 4Y1

GSK Investigational Site, Burlington

L1E 3C3

GSK Investigational Site, Courtice

N2C 2N9

GSK Investigational Site, Kitchener

P1B 2H3

GSK Investigational Site, North Bay

L1H 1C2

GSK Investigational Site, Oshawa

K9H 5G1

GSK Investigational Site, Peterborough

K9J 7B3

GSK Investigational Site, Peterborough

K7V 1P6

GSK Investigational Site, Renfrew

L8G 2V6

GSK Investigational Site, Stoney Creek

M3J 1N2

GSK Investigational Site, Toronto

H7T 2P5

GSK Investigational Site, Laval

H1V 1X4

GSK Investigational Site, Montreal

H3S 2W1

GSK Investigational Site, Montreal

H4N 2W2

GSK Investigational Site, Montreal

G6L 3J1

GSK Investigational Site, Plessisville

H9R 4S3

GSK Investigational Site, Pointe-Claire

G0S 2S0

GSK Investigational Site, Saint Insidore de Dorchester

G0A 4B0

GSK Investigational Site, Saint-Marc-des-Carrieres

J7Z 5T3

GSK Investigational Site, Sainte Jerome

J1H 1Z1

GSK Investigational Site, Sherbrooke

S4P 3X1

GSK Investigational Site, Regina

S7K 0M5

GSK Investigational Site, Saskatoon

602-739

GSK Investigational Site, Pusan

139-872

GSK Investigational Site, Seoul

480-821

GSK Investigational Site, Uijeongbu-si

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY